Cite
Daily low-dose cisplatin-based concurrent chemoradiotherapy in patients with uterine cervical cancer with emphasis on elderly patients: a phase 2 trial.
MLA
Mitsuhashi, Akira, et al. “Daily Low-Dose Cisplatin-Based Concurrent Chemoradiotherapy in Patients with Uterine Cervical Cancer with Emphasis on Elderly Patients: A Phase 2 Trial.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 23, no. 8, Oct. 2013, pp. 1453–58. EBSCOhost, https://doi.org/10.1097/IGC.0b013e3182559bda.
APA
Mitsuhashi, A., Uno, T., Usui, H., Nishikimi, K., Yamamoto, N., Watanabe, M., Tate, S., Hirashiki, K., Kato, K., Yamazawa, K., & Shozu, M. (2013). Daily low-dose cisplatin-based concurrent chemoradiotherapy in patients with uterine cervical cancer with emphasis on elderly patients: a phase 2 trial. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 23(8), 1453–1458. https://doi.org/10.1097/IGC.0b013e3182559bda
Chicago
Mitsuhashi, Akira, Takashi Uno, Hirokazu Usui, Kyoko Nishikimi, Noriko Yamamoto, Miho Watanabe, Shinichi Tate, et al. 2013. “Daily Low-Dose Cisplatin-Based Concurrent Chemoradiotherapy in Patients with Uterine Cervical Cancer with Emphasis on Elderly Patients: A Phase 2 Trial.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 23 (8): 1453–58. doi:10.1097/IGC.0b013e3182559bda.